Introduction
Allergic asthma is a chronic inflammatory disorder which is characterized by recurrent episodes of wheezing, shortness of breath, and coughing, usually in response to an environmental trigger. While the proteins from these sources trigger allergic asthma in some individuals, it is currently unclear what aspect of the allergen exerts its role in the induction of the immune response. One common denominator is that many of the known allergens contain proteolytic activity. We recently showed that removal of proteases from German cockroach (GC) feces (frass) attenuated airway hyperresponsiveness and mucin production in a mouse model of allergic airway disease [1] . It has also been shown that removal of proteases from Aspergillus fumigatus [2] decreased airway inflammation and airway hyperresponsiveness in mouse models. In addition, the proteolytic antigen Per a 10 from the Ameri-can cockroach [3] , Epi p1 from Epicoccum purpurascens [4] and Cur 11 from Curvularia lunata [5] also regulated airway inflammation and airway hyperresponsiveness in mouse models. These data suggest a role for the intrinsic proteases in allergens in modulating allergic airway disease; however, the mechanism by which this occurs is currently unclear.
It is likely that the innate immune response contributes to the initiation of allergic disease. The first cells to encounter airborne pathogens are resident airway cells including the airway epithelium, alveolar macrophages, and dendritic cells (DCs). Many in vitro studies have shown that proteases from house dust mites (HDM), cockroaches, and fungi activate the innate immune response by inducing cytokine [interleukin (IL)-6 and IL -8] and chemokine (GM-CSF) expression from the airway epithelium [6] [7] [8] [9] . Alveolar macrophages are also important secretory cells, and it has been shown that exposure of primary alveolar macrophages or the alveolar macrophage cell line derived from Balb/c mice (MHS cells) to HDM induced significant tumor necrosis factor-␣ (TNF ␣ ) production [10] . Mucosal DCs form a dense network associated with the airway epithelium and can form long extensions into the airway lumen [11] . Allergen-induced activation of DCs is well established [12] . While it is clear that allergens can directly act on the airway epithelium and alveolar macrophages in cell culture models, a role for intrinsic proteases in the initiation and regulation of the innate immune response has not been characterized in animal models.
One mechanism by which proteases may regulate immune responses is through the activation of proteaseactivated receptors (PARs). PARs are a family of seven transmembrane G-protein-coupled receptors stimulated by extracellular proteases. To date, four family members have been identified. Cleavage of an extracellular amino portion of the molecule by thrombin (for PAR-1, PAR-3, and PAR-4) or by trypsin (for PAR-2) results in a new amino terminus. The amino terminus now acts as a tethered ligand that binds to the activation site of the receptor to activate the heterotrimeric G-proteins in the cell membrane [13] . PAR-2 can also be activated, without proteolytic cleavage, using the peptides SLIGKV (human) or SLIGRL (mouse) [14] . PAR-2 has been implicated in allergic diseases and is expressed by many cells in the lung, including airway epithelial cells [15] , alveolar macrophages [16] , mast cells [17] , and DCs [16] . Allergens, including HDM [15] , mold [18] , and cockroach [19] , have been shown to cleave and activate PAR-2 in cell culture models. GC extract was found to specifically activate PAR-2, but not PAR-1, PAR-3, or PAR-4, using either blocking antibodies [20] or receptor desensitization [19] . Studies in airway epithelial cell culture have shown that PAR-2 activation regulated IL-8 production [20] , GM-CSF and eotaxin [21] , as well as mucin secretion [22] , thereby suggesting a mechanism by which PAR-2 can activate the innate immune response.
In this report, we investigated the role of protease-PAR-2 activation as an important trigger for the initiation of the innate immune response in vivo. In addition, since alveolar macrophages are among the first responders to inhaled substances, we will study the role of allergen-derived proteases on macrophage-derived cytokine production. To our knowledge, the effect of allergen-derived proteases and PAR-2 on macrophage activation or the initiation of the innate immune response in vivo has not been addressed. Our study presents evidence that proteases in GC frass can induce the innate immune response in mice via the activation of PAR-2. In addition, these proteases can directly activate alveolar macrophage cytokine production by the activation of the signaling mediators NF-B and extracellular regulated kinase (ERK). Together our data implicate an important role for allergenderived proteases in the initiation of the innate immune response and may further suggest a mechanism by which cockroaches produce a potent allergen.
Materials and Methods

Cockroach Frass
The fecal remnants (frass) from one cage of German cockroaches were transferred to a sterile container and stored at 4 ° C. GC frass was resuspended in PBS (divalent free; Gibco/Invitrogen, Carlsbad, Calif., USA) made with endotoxin-free double-distilled water (2 h at 4 ° C while rocking). Extracts were centrifuged to remove debris (13,000 g for 5 min at 4 ° C), supernatants harvested, and total protein was measured using the Bio-Rad Protein Assay Dye (Bio-Rad, Hercules, Calif., USA). To inhibit protease activity, frass was pretreated with aprotinin (a specific inhibitor of serine proteases; 10 g/ml for 30 min at 37 ° C) prior to use. The same concentration of aprotinin was added to PBS and used as a control. Protease activity was determined using the Azocoll assay as previously described [7] . GC frass was determined to contain 19 g protease activity/mg frass and aprotinin treatment inhibited 85% of the protease activity [23] and will hence be referred to as protease-depleted GC frass.
Animals
Six-week-old female Balb/c and PAR-2-deficient mice were obtained from the Jackson Laboratory (Bar Harbor, Me., USA). The PAR-2-deficient mice were on the C57BL/6 background, which has been documented to be the least responsive to allergen exposure via the airways [24] , thus necessitating the need to backcross these mice onto the Balb/c background. These studies conformed to the principles for laboratory animal research outlined by the Animal Welfare Act and the Department of Health, Education, and Welfare (National Institutes of Health). These studies were approved by the Institutional Animal Care and Use Committee of the Cincinnati Children's Hospital Medical Center.
Mouse Challenge Protocol
Mice were anesthetized with ketamine (45 mg/kg)/xylazine (8 mg/kg) prior to PBS or GC frass (40 g/40 l) exposure by a single inhalation as previously described [25] . For direct PAR-2 activation, we administered via intratracheal inhalation PAR-2-activating peptide (PAR-2-AP; SLIGRL-NH 2 ), or a scrambled control peptide (PAR-2-CP; LSIGRL-NH 2 ) obtained from Peptides International (Louisville, Ky., USA) at a concentration of 400 g/40 l in PBS. Eighteen hours later, mice were given a lethal dose of sodium pentobarbital.
Assessment of Airway Inflammation
Lungs were lavaged with 1 ml of Hanks' balanced salt solution without calcium or magnesium. The lavage fluid was centrifuged (300 g for 10 min), and the supernatant was removed for cytokine analysis and immediately stored at -80 ° C. The cell pellet was resuspended in 1 ml of 10% fetal bovine serum in PBS. Total cell numbers were counted on a hemocytometer; 200 l of the resuspended bronchoalveolar lavage (BAL) cells were centrifuged onto a microscope slide using the Cytospin II centrifuge (Shandon Thermo, Waltham, Mass., USA), for 10 min at 64 g at room temperature. Once dried, cells were stained with Diff-Quick (Thermo Electron, Pittsburg, Pa., USA) solution for differential cell counting, and 500-700 cells were counted per slide. BAL fluid was analyzed for keratinocyte-derived chemokine (KC) and TNF ␣ according to the manufacturer's specifications (R&D Systems, Minneapolis, Minn., USA).
Cell Culture BAL cells from naïve Balb/c or PAR-2-deficient mice were seeded onto 12-well plates (5 ! 10 5 cells/ml, 500 l/well) and incubated for 2 h at 37 ° C and 5% CO 2 . Residual adherent BAL macrophages ( 1 95% viability) were cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 2% fetal bovine serum and penicillin/streptomycin. A mouse alveolar macrophage cell line, MHS, purchased from American Type Culture Collection (Manassas, Va., USA) was cultured in DMEM (Invitrogen) supplemented with 10% fetal bovine serum and penicillin/streptomycin. Cells (1 ! 10 6 cells/ml, 1 ml/well) were seeded onto 6-well plates and grown to confluence at 37 ° C and 5% CO 2 . Once confluent, cells were rinsed with PBS (2 ! 1 ml), and 1 ml DMEM without serum was added per well. In all cases, cells were treated with PBS, aprotinin-pretreated PBS, GC frass (1 g/ml ) , and protease-depleted GC frass (1 g/ml ). In some cases, cells were pretreated with either dimethyl sulfoxide, isohelenin (30 M ; EMD Biosciences, San Diego, Calif., USA), PD98059 (30 M ; Cell Signaling Technology, Danvers, Mass., USA), and SB202190 (10 M ; Calbiochem, La Jolla, Calif., USA) for 1 h prior to treatment. Supernatants were harvested 18 h after treatment, clarified by centrifugation (13,000 g ) to remove any cellular debris, and analyzed for TNF ␣ by ELISA (R&D Systems).
Electrophoretic Mobility Shift Assay MHS cells (1 ! 10 6 cells/ml, 10 ml per 100-mm 2 cell culture dish) were grown to confluence. Once confluent, cells were rinsed twice with PBS and starved with 5 ml of DMEM without serum overnight. Cells were then treated with GC frass (1 g/ml) for 4 h. Nuclear proteins were isolated as previously described [26] . Protein concentrations were determined by Bio-Rad protein assay and stored at -70 ° C until use. The oligonucleotide probe encoding the consensus sequence of NF-B or AP-1 (Santa Cruz, Santa Cruz, Calif., USA) was labeled with [ ␥ -32 P]ATP using T4 polynucleotide kinase (Invitrogen) and purified in a MicroBiospin chromatography column. The gel was run using 10 g of nuclear protein as previously described [27] . Gels were transferred to Whatman 3M paper, dried under vacuum at 80 ° C for 1 h, and exposed using a Phosphoimager.
Immunoblot Analysis MHS cells (1 ! 10 6 cells/ml, 1 ml/well) were plated into 6-well plates and grown to confluence at 37 ° C and 5% CO 2 . Once confluent, cells were rinsed with PBS (2 ! 1 ml), and 1 ml DMEM without serum was added per well for 18 h. Cells were then treated with GC frass (1 g/ml) for 15, 30, 45, 60, or 90 min. Following the incubation, samples were extracted in a lysis buffer containing 50 m M Tris (pH 7.5), 40 m M ␤ -glycerophosphate, 100 m M NaCl, 2 m M EDTA, 50 m M NaF, 200 M Na 3 VO 4 , 200 M PMSF, and 1% Triton X-100 on ice for 10 min. Insoluble materials were removed by centrifugation (13,000 g for 10 min at 4 ° C); 50 g of each sample were loaded onto a 10% SDS-polyacrylamide gel. The gel was then transferred to nitrocellulose, which was then blocked in 5% milk/TBS-0.1% Tween 20 overnight at 4 ° C. After a 1-hour incubation with a 1: 1,000 dilution of anti-I B ␣ antibody (clone C21; Santa Cruz), ␤ -actin (clone C4; Santa Cruz), anti-phospho-ERK antibody (Thr202/Tyr204; Santa Cruz), or ERK antibody (clone MK12; Millipore, Billerica, Mass., USA) at room temperature, the nitrocellulose was washed in TBS-0.1% Tween 20, and 1: 10,000 dilution of the appropriate secondary antibody was added (goat anti-rabbit IgG or goat anti-mouse IgG, H&L chain-specific peroxidase conjugate, Calbiochem/EMD, Gibbstown, N.J., USA) for 1 h at room temperature. Following 4 rinses with TBS-0.1% Tween 20, signals were amplified and visualized using enhanced chemiluminescence Western blot detection reagent (GE Healthcare, Piscataway, N.J., USA).
Statistical Analysis
When applicable, statistical significance was assessed by oneway analysis of variance (ANOVA). Differences identified by ANOVA were pinpointed by Student-Newman-Keuls' multiple range test.
Results
Serine Proteases Regulate the Innate Immune Response to GC Frass Inhalation
To address the role of active serine proteases in modulating the innate immune response, we performed a single intratracheal inhalation of PBS, aprotinin, GC frass, or protease-depleted GC frass in naïve Balb/c mice. BAL fluid was harvested 18 h later and analyzed for the expression of the inflammatory cytokines TNF ␣ and KC as well as cellular infiltration. GC frass significantly induced the release of the inflammatory cytokines TNF ␣ and KC into the airways ( fig. 1 ) . Importantly, exposure to proteasedepleted GC frass significantly reduced the inflammatory response, as indicated by significantly decreased levels of TNF ␣ and KC in the airways. Next we determined the level of cellular infiltration into the airways of these mice. Inhalation of GC frass significantly increased the recruitment of neutrophils, macrophages, and lymphocytes into the lungs of mice ( table 1 ) . There was a significant reduction in the level of newly migrated neutrophils into the airways of mice exposed to protease-depleted GC frass, likely due to the decrease in KC levels. Interestingly, removal of protease from GC frass had no effect on alveolar macrophage recruitment. Together, these data suggest that the intrinsic proteases in GC frass regulate cytokine and chemokine production in vivo leading to decreased neutrophil migration into the airways.
Selective Activation of PAR-2 Increased the Innate Immune Response
To determine if PAR-2 was sufficient to mediate an innate immune response, we performed a single intratracheal inhalation of PAR-2-AP or PAR-2-CP. These peptides activate PAR-2 by bypassing the requirement for proteolytic cleavage. Importantly, we found that a single exposure to PAR-2-AP, but not PAR-2-CP, increased TNF ␣ and KC expression ( fig. 2 ). In addition, PAR-2-AP induced a significant increase in neutrophils and macrophages compared to PBS and PAR-2-CP ( table 2 ). These data confirm that selective activation of PAR-2 is sufficient to induce an innate immune response in vivo . (40 l) , and PBS pretreated with aprotinin (PBS-Ap), GC frass (40 g/40 l), or protease-depleted GC frass (GC frass-Ap); 18 h later, BAL fluid was harvested and differential cell counts performed. These data represent 5-7 mice per group and are expressed as means 8 SEM of cell numbers ! 10 4 and statistical significance was determined by ANOVA.
* p < 0.05 vs. PBS. Only neutrophils were significantly decreased in GC frass-Ap compared to GC frass (** p = 0.01).
Serine Proteases Regulate the Innate Immune Response to GC Frass Inhalation in a PAR-2-Dependent Manner
To address the role of PAR-2 in regulating the innate immune response to an inhaled allergen, we compared a single exposure of GC frass in wild-type and PAR-2-deficient mice. Exposure to GC frass induced a significant increase in TNF ␣ and KC expression in the BAL fluid, which was significantly decreased in PAR-2-deficient mice ( fig. 3 ). Concurrent with a decrease in KC, the major chemoattractant for neutrophils, we detect less neutrophil infiltration in PAR-2-deficient mice compared with wild-type mice following GC frass inhalation ( table 3 ) . Again, macrophage and lymphocyte migration were independent of protease-PAR-2 activation. Together, these data confirm that GC frass proteases play a role in modulating the early innate immune response through the activation of PAR-2.
GC Frass Regulates TNF ␣ Release from Alveolar Macrophages
Since macrophages express PAR-2 [28] and are a significant source of TNF ␣ , a crucial cytokine in the induction of the innate immune response, we focused the rest of this study on the regulation of TNF ␣ by cockroach proteases. Naïve mice were lavaged and alveolar macrophages were isolated and cultured for 18 h in the presence of GC frass or protease-depleted GC frass. We found that GC frass significantly increased TNF ␣ production from alveolar macrophages and removal of the active proteases significantly attenuated TNF ␣ production ( fig. 4 a) . Next, we exposed alveolar macrophages from wild-type and PAR-2-deficient mice to GC frass and the production of TNF ␣ was measured. A significant decrease in TNF ␣ Cell counts were statistically significant between PAR-2-AP and PBS in the wild type (* p < 0.05) and PAR-2-CP compared to PAR-2-AP (** p < 0.05).
release from PAR-2-deficient primary alveolar macrophages compared to wild-type alveolar macrophages ( fig. 4 b) was detected. These data confirm that GC frass activation of PAR-2 leads to TNF ␣ release from alveolar macrophages.
GC Frass-Induced TNF ␣ Expression Is Dependent on NF-B and ERK Activation in Macrophages
To address the signaling aspect of cytokine production, we switched to a murine alveolar macrophage cell line, MHS cells. We used a battery of chemical inhibitors to determine whether specific kinases were required for the GC frass activation of TNF ␣ . We found that inhibition of NF-B (isohelenin), and inhibition of ERK signaling (PD98059), but not the inhibition of p38 (SB202190), significantly attenuated GC frass-induced TNF ␣ production ( fig. 5 a) . To confirm the role of NF-B in mediating this response, we asked whether GC frass induced the degradation of I B ␣ , a major step in NF-B activation. MHS cells were cultured in the presence or absence of GC W ild-type (Balb/c) and PAR-2-deficient mice were exposed to a single inhalation of PBS (40 l) or GC frass (40 g/40 l); 18 h later, BAL fluid was harvested and differential cell counts performed. These data represent 4-6 mice per group and are expressed as means 8 SEM of cell numbers ! 10 4 and statistical significance was determined by ANOVA.
Cell counts were statistically significant between GC frass and PBS in the wild-type (* p < 0.05) and PAR-2-deficient mice (** p < 0.05). Only neutrophils were significantly decreased in PAR-2 mice compared to wild-type mice following GC frass exposure (*** p = 0.005). frass for increasing amounts of time, and a Western blot was performed for I B ␣ . GC frass induced a time-dependent decrease in I B ␣ levels ( fig. 5 b) . To confirm that I B ␣ degradation leads to NF-B translocation to the nucleus, we isolated the nuclear extracts of cells 4 h following treatment and studied NF-B-DNA binding using an electrophoretic mobility shift assay (EMSA). We found that NF-B translocated to the nucleus and bound to DNA ( fig. 5 d) . We also confirmed that GC frass induced ERK phosphorylation by Western blot ( fig. 5 c) . Since the transcription factor AP-1 is a downstream target of ERK, we asked whether GC frass activated AP-1. Nuclear extracts were analyzed for AP-1-DNA binding by EMSA. We found that GC frass induced AP-1-DNA binding in MHS cells, and this was significantly diminished when cells were treated with protease-depleted GC frass ( fig. 5 c) . Together these data suggest that GC frass can induce a robust signaling pathway consisting of activation of the transcription factors NF-B and AP-1 leading to TNF ␣ and KC cytokine expression.
Discussion
Important in the induction of the innate immune response are the inflammatory cytokines TNF ␣ and KC (the mouse homolog of human IL-8) and cellular recruitment of neutrophils and macrophages into the airways. Our finding that GC frass protease-PAR-2 activation regulated the innate immune response in vivo is novel and enhances our understanding of the role for proteases in mediating the innate immune response. Alveolar macrophages were shown to exhibit more intense staining for PAR-2 expression than other inflammatory cells in the airways [28] , and therefore we focused on these cells as potential mediators of the early innate immune response. Our data show that the proteases in a common allergen could mediate a signal transduction pathway leading to increased production of TNF ␣ and KC via activation of PAR-2. To our knowledge, this is the first report studying the role of allergen-derived proteases and the activation of PAR-2 in mediating the early innate immune response in an animal model. Alveolar macrophages are abundant in the alveolar spaces and are pivotal not only in the elimination of foreign substances but also the initiation of the inflammatory process. Alveolar macrophages have been shown to induce cytokines important in the innate immune response. For example, human alveolar macrophages were shown to induce TNF ␣ and IL-8 release following exposure to rhinovirus [29] . Treatment of MHS cells with A. fumigatus spores elicited increased TNF ␣ , MIP-1 ␣ , MIP-1 ␤ , and MCP-1 mRNA within 6 h [30] . A. fumigatus was also shown to induce TNF ␣ cytokine expression in GC frass proteases and PAR-2 mediate TNF ␣ release from alveolar macrophages. a BAL fluid from naïve Balb/c mice was cultured and treated with PBS, aprotinin-treated PBS, GC frass (1 g/ml), or protease-depleted GC frass (1 g/ml) for 18 h. Cell supernatants were harvested, clarified and analyzed for TNF ␣ by ELISA. * p ! 0.001 and * * p = 0.002 vs. control; * * * p = 0.004 vs. GC frass, n = 5 separate experiments. b BAL fluid from Balb/c and PAR-2-deficient mice were cultured and treated with PBS or GC frass (1 g/ml). * p ! 0.001 and * * p = 0.008 vs. PBS; * * * p = 0.004 vs. GC frass, n = 3 separate experiments. alveolar macrophages through the activation of ERK [31] . Alveolar macrophages are the most prevalent cells in the human airspace both in normal subjects and in asthmatics. Importantly, following antigen challenge, the increase in alveolar macrophages exceeds that of eosinophils, neutrophils, or lymphocytes [32] . Alveolar macrophage function was shown to be compromised in patients with poorly controlled asthma with a reduction in their ability to phagocytose [33] . In addition, in a study of asthmatic subjects, functional changes in the alveolar macrophages were identified, including an altered phenotype, enhanced antigen presentation, and an increased production of secretory products [34, 35] . A recent report has suggested a direct link between the number of alveolar macrophages in the lung and allergic airway inflammation in mice [36] . Thus, it is likely that the alveolar macrophage plays an important role not only in the induction of an innate immune response, but may also influence the adaptive immune response leading to asthma.
The concept that intrinsic allergen-derived proteases and PAR-2 may have direct immunomodulatory roles in vitro has been borne out in a number of studies. Allergenderived proteases have been shown to modulate cytokine expression from airway epithelial cells [6-8, 18, 37] . HDM protease Der p 1 was shown to increase permeability of the bronchial epithelium by cleaving the tight junction adhesion protein occludin [37] suggesting a mechanism for increased exposure of the allergen to DC. Human ␤ -defensin and CCL20, both of which are important mediators of innate immunity, were decreased in PAR-2-de- [38] . Thus, allergen-derived proteases through PAR-2 activation may serve as a link between the innate and adaptive immune response. HDM was also shown to activate chloride channels via PAR-2 in human airway epithelial cells [39] . Activation of PAR-2 with papain, trypsin, or fungi (Alternaria) induced airway epithelial cell expression of thymic stromal lymphopoietin [40] , which is thought to activate DCs to polarize naïve T cells to Th2 cells. Our study provides in vivo as well as in vitro evidence that GC frass proteases can activate the innate immune response and provides evidence that alveolar macrophages can respond to allergen-derived proteases via PAR-2.
In this work, we focused specifically on the role of the allergen-derived protease and PAR-2 on activation of the alveolar macrophage; however a direct role for this protease on the airway epithelium as well as macrophageepithelial cell interactions should also be considered. We did not directly study the role of the protease-PAR-2 activation in the mouse airway epithelium, but we have previously shown that GC extract proteases act through PAR-2 to mediate IL-8 cytokine production from human airway epithelial cells [20] . Lung macrophage-airway epithelial cell interactions may work in synergy to promote inflammatory responses. Interestingly, it was shown that various types of particulate matter induced cytokine release from epithelial cells but not alveolar macrophages; however, co-culture of alveolar macrophages with epithelial cells induced a synergistic increase in cytokine release (TNF ␣ and MIP-2) which was contact dependent [41] . The understanding that GC frass proteases act directly on alveolar macrophages as well as airway epithelium alone is the first step in understanding the more complex role of macrophage-epithelial interactions and needs to be investigated further in the future.
It is still unclear exactly what makes an allergen able to shift from tolerance to disease; however, our studies clearly show that protease-PAR-2 activation regulates the innate immune response in vivo. Since the innate immune response can activate adaptive immunity, proteases and the activation of PAR-2 may play an important role as an adjuvant in the initiation of allergic airway disease. Furthermore, the discovery of the protease-PAR-2 mechanism at the forefront of the immune response promotes PAR-2 as novel therapeutic targets for the treatment of inflammation.
